St. Luke's Cystic Fibrosis Center of Idaho — Boise, Idaho

St. Luke's Cystic Fibrosis Center of Idaho is a clinical research site located in Boise, Idaho, United States 83702.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

St. Luke's Cystic Fibrosis Center of Idaho has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Covid19, Corona Virus Infection, Coronavirus.

Sponsors: Sound Pharmaceuticals, Incorporated, Vertex Pharmaceuticals Incorporated, Alcresta Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for St. Luke's Cystic Fibrosis Center of Idaho?

St. Luke's Cystic Fibrosis Center of Idaho has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has St. Luke's Cystic Fibrosis Center of Idaho conducted?

St. Luke's Cystic Fibrosis Center of Idaho has 9 clinical trials on record, with 1 currently active. Their work covers Covid19, Corona Virus Infection, Coronavirus.

Is St. Luke's Cystic Fibrosis Center of Idaho accredited by Crixeo Health?

Yes — St. Luke's Cystic Fibrosis Center of Idaho holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about St. Luke's Cystic Fibrosis Center of Idaho?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.